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Throughout the world of public health, and environmental health in
particular, we work with lawyers; yet, many of us remain unaware of
recent developments in the law and legal scholarship that may be crit-
ical to the success of our work. Many lawyers, even those working on
major public health challenges such as tobacco control, are similarly
unaware of relevant changes in the world of science. There is a new
but growing effort to provide lawyers and the legal community with
deeper understanding of public health and the science that guides it.
I urge the public health and environmental health community to
participate.
Recently, I have watched how lawyers in the Justice Department
have handled the Vaccine Injury Compensation Program, perhaps
unaware of the population perspective underlying immunization;
these lawyers have done what they are trained to do—be adversaries.
This no-fault compensation program was created as a way to elimi-
nate fear of injury as an obstacle to protecting a population, but
lawyers have routinely contested the claims for injured children cov-
ered by the statute. A little public health training would have made
a big difference in how these cases have been handled and how the
lawyers responded to the claims. 
Over the last 30 years, law in the United States has grounded
individual rights in the Constitution, statutes, court decisions, and
accompanying legal scholarship. This tradition protects all
Americans from certain threats. However, public health, which must
protect Americans from threats to their health, has not prospered in
a society focused on individuals and curative medicine. American law
emphasizes the rights of individuals, attending little to common
issues of groups or societal concerns. One way to give new attention
to public health would be to elaborate within American jurispru-
dence a new foundation in the law: population-based legal analysis.
By tradition, American law attends to persons, including corporate
persons, in ways that have no analog for populations. The science of
epidemiology did not exist at the inception of our legal system, but
today in public policy—including legislation, regulation, and litiga-
tion—debate centers on matters of population-based science. Congress
is considering tort reform; the Data Quality Act (Office of
Management and Budget 2002) produced a large number of new fed-
eral regulations about how government agencies may use scientific
data; Daubert hearings (Project on Scientific Knowledge and Public
Policy 2003), based on a 10-year-old Supreme Court decision and its
progeny, dominate product liability and toxic tort litigation; and the
American Law Institute is revisiting its Restatement of Torts
(American Law Institute 2003) that proposes to tell judges and others
how scientists determine causation. How can legal education catch up? 
For the last few years, I have collaborated with colleagues at
Northeastern University School of Law (Boston, MA), first in creat-
ing a JD/MPH (Juris Doctor/Master of Public Health) dual degree
program (Tufts School of Medicine 2001), and then the Public
Health Advocacy Institute (Boston, MA). One of the problems we
have taken on is public health literacy for lawyers—how to introduce
law students and lawyers to the population perspective of public
health and how to do so by teaching them public health context, pub-
lic health powers, and public health methods. (This effort, which was
explored at a national meeting, “Public Health Literacy for Lawyers”
held 11–13 April in Boston, Massachusetts,
is hindered by law school admission stan-
dards that do not require any special quanti-
tative ability, although these skills are
increasingly required in many aspects of legal practice, for example,
for handling epidemiologic evidence.)
Some have suggested additional elective courses on public health
topics (e.g., environmental law, HIV/AIDS, food and drug law, etc.)
(Goodman et al. 2002), but only students already committed to
addressing these issues enroll. Thus, a new strategy has been pro-
posed (Parmet and Robbins 2002), one that incorporates public
health materials in core law school courses such as torts, constitu-
tional law, and administrative law. As part of the exposition and dis-
cussion of major teaching cases, law professors would use the
long-neglected underlying public health facts and analysis originally
associated with them. For this public health slant to be attractive to
legal educators and law schools, a scholarly approach is necessary—
one that expands application of population-based analysis in the law
and then demonstrates its utility to lawyers. 
Population-based legal analysis, the core of teaching public
health to lawyers, can be useful to lawyers beyond public health
problems. Environmental lawyers and scholars are already coping
with epidemiology and causation issues. Lawyers, more generally,
will find that their understanding of populations contributes broadly
to comprehension of the law involving groups—not limited to
studying disease and injury-causing exposures and societal interven-
tions. Legal scholarship will be able to use population science to
address legal questions of disparate impact and discrimination by
race, age, and sex. Labor law, civil rights law, and even telecommuni-
cations law all focus on allocations and thus populations. 
Legal scholars are moving toward conscious development of pop-
ulation-based legal analysis, but we in public health, environmental
health, and epidemiology can contribute our support and talents to
the effort. We must provide the public health background, critical
evidence, methodologic analysis, and epidemiologic details to engage
lawyers in the public health issues that underlie dozens of classic law
school teaching cases. Progress in our own fields may depend on
well-educated legal allies.
Work on population-based legal analysis has started, and there
are precedents for bringing new scholarly domains into the law.
Starting 25 years ago, with generous funding from conservative
foundations, the law and economics movement successfully intro-
duced microeconomic theory and the logic of markets to legal
scholarship and education. Economics, as understood by most
lawyers, is far removed from calculations and equations used by
econometricians, but as a field, American law accepts the notion
that neoclassical economics is a way to understand and assess
human decisions, particularly choices of risks and benefits. Market
doctrines are now built into legal decision making (Parmet and
Robbins 2002). A similar concerted effort will reward public health
by building our concern for populations into American law. 
I thank W.E. Parmet, R.A. Daynard, W.K. Mariner, and
P. Freeman for their contributions to my thinking and for reviewing
drafts of this editorial.
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EHP has a long-standing requirement for authors to disclose com-
peting financial interests. Corresponding authors are required to
submit a declaration of competing financial interests on behalf of all
authors involved. However, until recently we did not publish this
information with the article. In May 2003, we began publishing the
authors’ disclosure declarations. The statements provide either a dis-
closure of competing financial interests along with a brief description,
a declaration of no competing interests, or a declination to provide
such information.
Our full disclosure policy was established because we are mind-
ful of our obligation to provide responsible and effective oversight to
manuscripts published in the journal. We believe it is vital for EHP
to ensure that information published in the journal is presented in
an objective and balanced manner and that readers have the oppor-
tunity to judge for themselves whether bias has been introduced
because of any competing interests of the authors. EHP’s policy of
disclosure applies to research articles, commentaries, reviews, and
correspondence. Although full disclosure is important, we believe
that a decision to publish an article should not be based on a decla-
ration of a competing interest.
Our requirements for full disclosure also extend to reviewers
and editors, who must disclose to the Editor-in-Chief any com-
peting financial interests that could be construed as affecting their
evaluation of a manuscript. Reviewers or editors might be asked
to recuse themselves, when appropriate. However, reviewers and
editors are not automatically disqualified because of a competing
financial interest.
Competing financial interests may include, but are not limited
to, grant support, employment (recent, present, or anticipated), and
personal financial interests by the author(s), immediate family mem-
bers, or institutional affiliations that may gain or lose financially
through publication. Increasingly, researchers are compensated by a
host of financial arrangements such as travel, consultancies, advisory
board positions, patent and royalty arrangements, stock shares,
bonds, and the like. Diversified mutual funds or investment trusts
do not constitute a competing financial interest. Further, authors are
required to certify that their freedom to design, conduct, interpret,
and publish research is not compromised by any controlling sponsor
as a condition of review and publication.
Since disclosure statements have been published with EHP arti-
cles, we have received comments from some readers questioning the
accuracy of competing financial interest declarations made by a few
authors. As is the case for most journals, EHP is not in the position
to confirm the accuracy of disclosure statements made by our
authors. We rely on the veracity of the authors. However, authors
can expect scrutiny of their statements by EHP readers and the
authors’ own employers. We welcome this assistance as well as let-
ters to the editor that address alleged inaccuracies of competing
interest declarations.
Scientists are aware of the absolute necessity to maintain per-
sonal integrity, upon which science and our careers depend. It is
this integrity that full disclosure of competing interests is intended
to preserve. Therefore, it is imperative that authors and readers
understand that a disclosure of a competing interest does not
imply that the information in the article is questionable or the
conclusions biased. Authors must also understand that the omis-
sion of a pertinent financial interest, that is later revealed could
deal a severe blow to the authors’ integrity and research. 
We can expect that the beneficial mixing of academic, industrial,
and government-funded research will grow because of the complex-
ity of biomedical and environmental health research. With this
growth will come an increase in the competing financial interests of
researchers. Journal editors and authors must work together to
ensure the continuation of open communication and scientific
objectivity.
Thomas J. Goehl
Editor-in-Chief, EHP
Research Triangle Park, North Carolina 
E-mail: goehl@niehs.nih.gov
James G. Burkhart
Science Editor, EHP 
Research Triangle Park, North Carolina 
E-mail: burkhart@niehs.nih.gov
Note from the Editors: Full Disclosure Policy